179 related articles for article (PubMed ID: 16901893)
1. Control of MyoD function during initiation of muscle differentiation by an autocrine signaling pathway activated by insulin-like growth factor-II.
Wilson EM; Rotwein P
J Biol Chem; 2006 Oct; 281(40):29962-71. PubMed ID: 16901893
[TBL] [Abstract][Full Text] [Related]
2. Permissive roles of phosphatidyl inositol 3-kinase and Akt in skeletal myocyte maturation.
Wilson EM; Tureckova J; Rotwein P
Mol Biol Cell; 2004 Feb; 15(2):497-505. PubMed ID: 14595115
[TBL] [Abstract][Full Text] [Related]
3. Autocrine growth factor signaling by insulin-like growth factor-II mediates MyoD-stimulated myocyte maturation.
Wilson EM; Hsieh MM; Rotwein P
J Biol Chem; 2003 Oct; 278(42):41109-13. PubMed ID: 12941952
[TBL] [Abstract][Full Text] [Related]
4. Coordinate control of muscle cell survival by distinct insulin-like growth factor activated signaling pathways.
Lawlor MA; Rotwein P
J Cell Biol; 2000 Dec; 151(6):1131-40. PubMed ID: 11121430
[TBL] [Abstract][Full Text] [Related]
5. Effects of insulin like growth factors on early embryonic chick limb myogenesis.
Mohammed RH; Anderton H; Brameld JM; Sweetman D
PLoS One; 2017; 12(10):e0185775. PubMed ID: 28972999
[TBL] [Abstract][Full Text] [Related]
6. TGF-β inhibits muscle differentiation by blocking autocrine signaling pathways initiated by IGF-II.
Gardner S; Alzhanov D; Knollman P; Kuninger D; Rotwein P
Mol Endocrinol; 2011 Jan; 25(1):128-37. PubMed ID: 21106882
[TBL] [Abstract][Full Text] [Related]
7. Effects of myogenin on expression of late muscle genes through MyoD-dependent chromatin remodeling ability of myogenin.
Du C; Jin YQ; Qi JJ; Ji ZX; Li SY; An GS; Jia HT; Ni JH
Mol Cells; 2012 Aug; 34(2):133-42. PubMed ID: 22814845
[TBL] [Abstract][Full Text] [Related]
8. NOV/CCN3 impairs muscle cell commitment and differentiation.
Calhabeu F; Lafont J; Le Dreau G; Laurent M; Kazazian C; Schaeffer L; Martinerie C; Dubois C
Exp Cell Res; 2006 Jun; 312(10):1876-89. PubMed ID: 16600215
[TBL] [Abstract][Full Text] [Related]
9. IGFs and muscle differentiation.
Florini JR; Ewton DZ; Magri KA; Mangiacapra FJ
Adv Exp Med Biol; 1993; 343():319-26. PubMed ID: 8184742
[TBL] [Abstract][Full Text] [Related]
10. Role of phosphatidylinositol 3,4,5-trisphosphate (PIP3) 5-phosphatase skeletal muscle- and kidney-enriched inositol polyphosphate phosphatase (SKIP) in myoblast differentiation.
Ijuin T; Takenawa T
J Biol Chem; 2012 Sep; 287(37):31330-41. PubMed ID: 22815484
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor-1 suppresses the Myostatin signaling pathway during myogenic differentiation.
Retamales A; Zuloaga R; Valenzuela CA; Gallardo-Escarate C; Molina A; Valdés JA
Biochem Biophys Res Commun; 2015 Aug; 464(2):596-602. PubMed ID: 26151859
[TBL] [Abstract][Full Text] [Related]
12. Hesperedin promotes MyoD-induced myogenic differentiation in vitro and in vivo.
Jeong H; Lee JY; Jang EJ; Lee EH; Bae MA; Hong JH; Hwang ES
Br J Pharmacol; 2011 Jun; 163(3):598-608. PubMed ID: 21265826
[TBL] [Abstract][Full Text] [Related]
13. E47 phosphorylation by p38 MAPK promotes MyoD/E47 association and muscle-specific gene transcription.
Lluís F; Ballestar E; Suelves M; Esteller M; Muñoz-Cánoves P
EMBO J; 2005 Mar; 24(5):974-84. PubMed ID: 15719023
[TBL] [Abstract][Full Text] [Related]
14. The orphan nuclear receptor, COUP-TF II, inhibits myogenesis by post-transcriptional regulation of MyoD function: COUP-TF II directly interacts with p300 and myoD.
Bailey P; Sartorelli V; Hamamori Y; Muscat GE
Nucleic Acids Res; 1998 Dec; 26(23):5501-10. PubMed ID: 9826778
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor (IGF) binding protein-5 blocks skeletal muscle differentiation by inhibiting IGF actions.
Mukherjee A; Wilson EM; Rotwein P
Mol Endocrinol; 2008 Jan; 22(1):206-15. PubMed ID: 17885206
[TBL] [Abstract][Full Text] [Related]
16. Mirk/dyrk1B decreases the nuclear accumulation of class II histone deacetylases during skeletal muscle differentiation.
Deng X; Ewton DZ; Mercer SE; Friedman E
J Biol Chem; 2005 Feb; 280(6):4894-905. PubMed ID: 15546868
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone and the insulin-like growth factor system in myogenesis.
Florini JR; Ewton DZ; Coolican SA
Endocr Rev; 1996 Oct; 17(5):481-517. PubMed ID: 8897022
[TBL] [Abstract][Full Text] [Related]
18. Autonomous differentiation in the mouse myogenic cell line, C2, involves a mutual positive control between insulin-like growth factor II and MyoD, operating as early as at the myoblast stage.
Montarras D; Aurade F; Johnson T; IIan J; Gros F; Pinset C
J Cell Sci; 1996 Mar; 109 ( Pt 3)():551-60. PubMed ID: 8907701
[TBL] [Abstract][Full Text] [Related]
19. Subtilisin-like proprotein convertase PACE4 is required for skeletal muscle differentiation.
Yuasa K; Masuda T; Yoshikawa C; Nagahama M; Matsuda Y; Tsuji A
J Biochem; 2009 Sep; 146(3):407-15. PubMed ID: 19520771
[TBL] [Abstract][Full Text] [Related]
20. p38α MAPK disables KMT1A-mediated repression of myogenic differentiation program.
Chatterjee B; Wolff DW; Jothi M; Mal M; Mal AK
Skelet Muscle; 2016; 6():28. PubMed ID: 27551368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
